[PDF][PDF] Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy
WF Symmans, F Peintinger, C Hatzis, R Rajan… - J clin Oncol, 2007 - academia.edu
J clin Oncol, 2007•academia.edu
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant
Chemotherapy Page 1 Measurement of Residual Breast Cancer Burden to Predict Survival
After Neoadjuvant Chemotherapy W. Fraser Symmans, Florentia Peintinger, Christos Hatzis,
Radhika Rajan, Henry Kuerer, Vicente Valero, Lina Assad, Anna Poniecka, Bryan Hennessy,
Marjorie Green, Aman U. Buzdar, S. Eva Singletary, Gabriel N. Hortobagyi, and Lajos Pusztai A
B S T R A C T Purpose To measure residual disease after neoadjuvant chemotherapy in order …
Chemotherapy Page 1 Measurement of Residual Breast Cancer Burden to Predict Survival
After Neoadjuvant Chemotherapy W. Fraser Symmans, Florentia Peintinger, Christos Hatzis,
Radhika Rajan, Henry Kuerer, Vicente Valero, Lina Assad, Anna Poniecka, Bryan Hennessy,
Marjorie Green, Aman U. Buzdar, S. Eva Singletary, Gabriel N. Hortobagyi, and Lajos Pusztai A
B S T R A C T Purpose To measure residual disease after neoadjuvant chemotherapy in order …
Purpose
To measure residual disease after neoadjuvant chemotherapy in order to improve the prognostic information that can be obtained from evaluating pathologic response.
academia.edu
